InsidersTradesSigma
Track the BioInvent International Aktiebolag share price and the full management transaction log of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, BioInvent International Aktiebolag has logged 2 public disclosures. Market capitalisation: €1.6bn. The latest transaction was filed on 29 May 2026 (Purchase). Among the most active insiders: Stefan Eriksson. The full history is accessible without an account.
Analysts rate BioInvent International Aktiebolag Strong Buy (bullish), based on 3 analysts. Average price target: SEK 95.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
BioInvent International Aktiebolag is a Swedish biopharmaceutical company focused on developing treatments for cancer. It is listed on the Stockholm Stock Exchange under the symbol XSTO.